Host immunity ignored in clinical oncology: a medical opinion

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer biotherapy & radiopharmaceuticals 2005-04, Vol.20 (2), p.123-125
Hauptverfasser:	Elliott, Robert L, Head, Jonathan F
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Vaccines - therapeutic use Humans Immunotherapy - methods Immunotherapy - trends Interleukin-2 - immunology Lymphocytes - cytology Medical Oncology - methods Neoplasms - immunology Neoplasms - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	125
container_issue	2
container_start_page	123
container_title	Cancer biotherapy & radiopharmaceuticals
container_volume	20
creator	Elliott, Robert L Head, Jonathan F
description
doi_str_mv	10.1089/cbr.2005.20.123
format	Article
fullrecord	<record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_67790477</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67790477</sourcerecordid><originalsourceid>FETCH-LOGICAL-p124t-febd4aac67dda3b734ddff8c128041fd2a2763496fda692e19bc56b3f2fdca093</originalsourceid><addsrcrecordid>eNo1T7tOwzAA9ACipTCzIU9sKX7FjpEYUAUUqRILzJGflZFjhzgZ8vdEalnupLvT6Q6AO4y2GDXy0ehhSxCqF9hiQi_AepFZJUVTr8B1KT8IIY64uAIrXDdcMlavwfM-lxGGrptSGGcYjikPzsKQoIkhBaMizMnkmI_zE1Swc_ak9YuZ0w249CoWd3vmDfh-e_3a7avD5_vH7uVQ9ZiwsfJOW6aU4cJaRbWgzFrvG4NJgxj2ligiOGWSe6u4JA5LbWquqSfeGoUk3YCHU28_5N_JlbHtQjEuRpVcnkrLhZCICbEE78_BSS9b234InRrm9v8w_QP10Vb5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67790477</pqid></control><display><type>article</type><title>Host immunity ignored in clinical oncology: a medical opinion</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><creator>Elliott, Robert L ; Head, Jonathan F</creator><creatorcontrib>Elliott, Robert L ; Head, Jonathan F</creatorcontrib><identifier>ISSN: 1084-9785</identifier><identifier>DOI: 10.1089/cbr.2005.20.123</identifier><identifier>PMID: 15869445</identifier><language>eng</language><publisher>United States</publisher><subject>Cancer Vaccines - therapeutic use ; Humans ; Immunotherapy - methods ; Immunotherapy - trends ; Interleukin-2 - immunology ; Lymphocytes - cytology ; Medical Oncology - methods ; Neoplasms - immunology ; Neoplasms - therapy</subject><ispartof>Cancer biotherapy & radiopharmaceuticals, 2005-04, Vol.20 (2), p.123-125</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15869445$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Elliott, Robert L</creatorcontrib><creatorcontrib>Head, Jonathan F</creatorcontrib><title>Host immunity ignored in clinical oncology: a medical opinion</title><title>Cancer biotherapy & radiopharmaceuticals</title><addtitle>Cancer Biother Radiopharm</addtitle><subject>Cancer Vaccines - therapeutic use</subject><subject>Humans</subject><subject>Immunotherapy - methods</subject><subject>Immunotherapy - trends</subject><subject>Interleukin-2 - immunology</subject><subject>Lymphocytes - cytology</subject><subject>Medical Oncology - methods</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - therapy</subject><issn>1084-9785</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1T7tOwzAA9ACipTCzIU9sKX7FjpEYUAUUqRILzJGflZFjhzgZ8vdEalnupLvT6Q6AO4y2GDXy0ehhSxCqF9hiQi_AepFZJUVTr8B1KT8IIY64uAIrXDdcMlavwfM-lxGGrptSGGcYjikPzsKQoIkhBaMizMnkmI_zE1Swc_ak9YuZ0w249CoWd3vmDfh-e_3a7avD5_vH7uVQ9ZiwsfJOW6aU4cJaRbWgzFrvG4NJgxj2ligiOGWSe6u4JA5LbWquqSfeGoUk3YCHU28_5N_JlbHtQjEuRpVcnkrLhZCICbEE78_BSS9b234InRrm9v8w_QP10Vb5</recordid><startdate>200504</startdate><enddate>200504</enddate><creator>Elliott, Robert L</creator><creator>Head, Jonathan F</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200504</creationdate><title>Host immunity ignored in clinical oncology: a medical opinion</title><author>Elliott, Robert L ; Head, Jonathan F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p124t-febd4aac67dda3b734ddff8c128041fd2a2763496fda692e19bc56b3f2fdca093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Cancer Vaccines - therapeutic use</topic><topic>Humans</topic><topic>Immunotherapy - methods</topic><topic>Immunotherapy - trends</topic><topic>Interleukin-2 - immunology</topic><topic>Lymphocytes - cytology</topic><topic>Medical Oncology - methods</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elliott, Robert L</creatorcontrib><creatorcontrib>Head, Jonathan F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer biotherapy & radiopharmaceuticals</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elliott, Robert L</au><au>Head, Jonathan F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Host immunity ignored in clinical oncology: a medical opinion</atitle><jtitle>Cancer biotherapy & radiopharmaceuticals</jtitle><addtitle>Cancer Biother Radiopharm</addtitle><date>2005-04</date><risdate>2005</risdate><volume>20</volume><issue>2</issue><spage>123</spage><epage>125</epage><pages>123-125</pages><issn>1084-9785</issn><cop>United States</cop><pmid>15869445</pmid><doi>10.1089/cbr.2005.20.123</doi><tpages>3</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 1084-9785
ispartof	Cancer biotherapy & radiopharmaceuticals, 2005-04, Vol.20 (2), p.123-125
issn	1084-9785
language	eng
recordid	cdi_proquest_miscellaneous_67790477
source	Mary Ann Liebert Online Subscription; MEDLINE
subjects	Cancer Vaccines - therapeutic use Humans Immunotherapy - methods Immunotherapy - trends Interleukin-2 - immunology Lymphocytes - cytology Medical Oncology - methods Neoplasms - immunology Neoplasms - therapy
title	Host immunity ignored in clinical oncology: a medical opinion
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T02%3A07%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Host%20immunity%20ignored%20in%20clinical%20oncology:%20a%20medical%20opinion&rft.jtitle=Cancer%20biotherapy%20&%20radiopharmaceuticals&rft.au=Elliott,%20Robert%20L&rft.date=2005-04&rft.volume=20&rft.issue=2&rft.spage=123&rft.epage=125&rft.pages=123-125&rft.issn=1084-9785&rft_id=info:doi/10.1089/cbr.2005.20.123&rft_dat=%3Cproquest_pubme%3E67790477%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67790477&rft_id=info:pmid/15869445&rfr_iscdi=true